Investor Relations

Neuromind Biopharma is an emerging international Biopharmaceutical company specialising in research and development in the bio–pharmaceutics space. Our entry into the psychedelic arena is backed by its long history of developing therapeutics of natural origin and taking the lead from nature. We wish to further the science of harnessing the extensive source of tryptamine compounds creating a new class of therapeutics.

Investor Queries: ir@neuromindbiopharma.com